Frequency of, and Prognostic Factors for, Residual Thrombosis and Complete Veno-Occlusion Following Anticoagulation for Provoked Venous Thromboembolism (VTE) in Patients <21 years: Findings from the Kids-DOTT Multinational Trial

Oklahoma (O. Khan, MD) ; and University Hospital Wien, Vienna, Austria (C. Male, MD) . The Kids-DOTT trial was supported by 2 U01 grants (Clinical Coordinating Center, Data Coordinating Center) from the NIH NHLBI, and previously via a American Society of Hematology Bridge Grant, an institutional research grant from the Johns Hopkins All Children's Foundation, an NIH NHLBI K23 award, and a Hemophilia and Thrombosis Research Society Thrombosis Studies Award.r Hospital of Chicago, Chicago, Illinois (R. Bhat, MD) ; Boston Children's Hospital/Harvard University, Boston, Massachusetts (C. Trenor, MD/R.Grace, MD) ; Children's Hospital of Alabama/University of Alabama at Birmingham, Birmingham Alabama (L. Hilliard, MD/H. Wilson, MD) ; Children's Hospital of Atlanta/Emory University, Atlanta, Georgia (K. Patel, MD/G. Woods, MD) ; Children's Hospital of the King's Daughters, Norfolk, Virginia (G. Woods, MD;/E. Lowe, MD) ; Children's Hospital of Los Angeles/University of Southern California, Los Angeles, California (J. Jaffray, MD/G. Young, MD) ; Children's Hospital of Michigan/Wayne State University, Detroit, Michigan (M. Rajpurkar) ; Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, New York (J. Davila, MD) ; Children's Hospital of Orange County/University of California-Irvine, Irvine, California (A. Mahajerin, MD) ; Children's Hospital of Pittsburgh/University of Pittsburgh, Pittsburgh, Pennsylvania (S. Gunawardena, MD/J. Cooper, MD) ; Children's Medical Center Dallas/University of Texas Southwestern, Dallas, Texas (A. Zia, MD/J. Journeycake, MD) ; Children's Mercy Hospital, Kansas City, Missouri (S. Carpenter, MD) ; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (C. Tarango, MD) ; Cohen Children's Medical Center/Hofstra-Northshore Long Island Jewish School of Medicine, New York, New York (S. Acharya, MD) ; Dell Children's Hospital, Austin, Texas (L, Shaffer, MD/R. Mignacca, MD) ; Golisano Children's Hospital/University of Rochester, Rochester, New York (C. Mullen, MD, PhD) ; Helen Devos Children's Hospital, Grand Rapids, Michigan (D. Mitchell, MD) ; Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana (C. Nakar, MD) ; Johns Hopkins Children's Center/Johns Hopkins University, Baltimore, Maryland (C. Takemoto, MD/C. Lawrence, MD) ; Lucille Packard Children's Hospital/Stanford University, Palo Alto, California (C. Lo, MD) ; Michigan State University, East Lansing, Michigan (R. Kulkarni, MD/A. Scott-Emuakpor, MD) ; Nationwide Children's Hospital/The Ohio State University, Columbus, Ohio (S. O'Brien, MD/R. Kumar, MD) ; Nicklaus Children's Hospital/University of Miami, Miami, Florida (F. Corrales-Medina, MD) ; Newark Beth Israel Medical Center/Barnabas Health, Newark, New Jersey (S. Narang, MD) ; New York Presbyterian/Weill Cornell Medical Center, New York, New York (N. Kucine, MD) ; Norton Children's Hospital/University of Louisville, Louisville, Kentucky (A. Panigrahi, MD/K. McGowan, MD) ; Palmetto Health Children's Hospital, Palmetto, South Carolina (S. Cramer, MD) ; Penn State Children's Hospital/Penn State University, Hershey, Pennsylvania (S. Dandekar, MD/F. Xavier, MD) ; Primary Children's Hospital/University of Utah, Salt Lake City, Utah (A. Verma, MD) ; Rady Children's Hospital/University of California San Diego, San Diego, California (C. Thornburg, MD) ; Rainbow Babies and Children's Hospital/Wake Forest University, Cleveland, Ohio (S. Ahuja, MD) ; Saint Christopher's Hospital for Children/Drexel University, Philadelphia, Pennsylvania (D. Raybagkar, MD) ; Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, Netherlands (H. van Ommen, MD) ; Stead Family Children's Hospital/University of Iowa, Iowa City, Iowa (A. Sharathkumar, MD) ; Stollery Children's Hospital/University of Alberta, Edmonton, Alberta, Canada (P. Massicotte, MD) ; University of Oklahoma, Oklahoma City,r Oklahoma (O. Khan, MD) ; and University Hospital Wien, Vienna, Austria (C. Male, MD) . The Kids-DOTT trial was supported by 2 U01 grants (Clinical Coordinating Center, Data Coordinating Center) from the NIH NHLBI, and previously via a American Society of Hematology Bridge Grant, an institutional research grant from the Johns Hopkins All Children's Foundation, an NIH NHLBI K23 award, and a Hemophilia and Thrombosis Research Society Thrombosis Studies Award.